HIV Infection Clinical Trials in Washington D.C., District of Columbia
9 recruitingWashington D.C., District of Columbia
Showing 1–9 of 9 trials
Recruiting
Phase 2
A Clinical Trial of Combination HIV-Specific Broadly Neutralizing Monoclonal Antibodies Combined With ART Initiation During Acute HIV Infection to Induce HIV Remission
Acute HIV Infection
National Institute of Allergy and Infectious Diseases (NIAID)48 enrolled36 locationsNCT05719441
Recruiting
Phase 3
A Study to Evaluate the Effectiveness of Long-acting (LA) Cabotegravir (CAB) + Rilpivirine (RPV) LA When Given to Participants With Detectable HIV-1
HIV Infections
ViiV Healthcare332 enrolled89 locationsNCT06694805
Recruiting
Phase 2
Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer
HIV InfectionAnal Squamous Cell CarcinomaStage II Rectal Cancer AJCC v8+7 more
National Cancer Institute (NCI)40 enrolled14 locationsNCT04929028
Recruiting
Not Applicable
Impact of Behavior Modification Interventions and Lung Cancer Screening on Smoking Cessation in People Living With HIV: A Feasibility Study
HIV InfectionTobacco-Related Carcinoma
AIDS Malignancy Consortium100 enrolled11 locationsNCT04949464
Recruiting
Not Applicable
Peer Behavioral Activation Utilization to Improve Substance Use and HIV Outcomes in People Receiving Long Acting Injectable-PrEP/ART (PUSH)
HIV InfectionsSubstance Use
University of Maryland, Baltimore186 enrolled2 locationsNCT06501781
Recruiting
Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers
Anal CarcinomaMalignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+9 more
AIDS Malignancy Consortium200 enrolled8 locationsNCT05663502
Recruiting
Not Applicable
Intervention to Enhance PrEP Persistence
HIV PreventionHIV Infection Primary
Brown University300 enrolled3 locationsNCT06872307
Recruiting
Phase 1Phase 2
Pharmacokinetics, Safety, Tolerability of Dolutegravir/Rilpivirine in Pediatrics
HIV Infections
ViiV Healthcare20 enrolled8 locationsNCT05674656
Recruiting
Not Applicable
Comparing Mobile Health Strategies to Improve Pre-exposure Prophylaxis Use (PrEP) for HIV Prevention
HIV InfectionsSexually Transmitted Diseases
Public Health Foundation Enterprises, Inc.300 enrolled4 locationsNCT04855773